Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 20;188(4):978-997.e25.
doi: 10.1016/j.cell.2024.12.004. Epub 2025 Jan 16.

A biophysical basis for the spreading behavior and limited diffusion of Xist

Affiliations

A biophysical basis for the spreading behavior and limited diffusion of Xist

Mingrui Ding et al. Cell. .

Abstract

Xist RNA initiates X inactivation as it spreads in cis across the chromosome. Here, we reveal a biophysical basis for its cis-limited diffusion. Xist RNA and HNRNPK together drive a liquid-liquid phase separation (LLPS) that encapsulates the chromosome. HNRNPK droplets pull on Xist and internalize the RNA. Once internalized, Xist induces a further phase transition and "softens" the HNRNPK droplet. Xist alters the condensate's deformability, adhesiveness, and wetting properties in vitro. Other Xist-interacting proteins are internalized and entrapped within the droplet, resulting in a concentration of Xist and protein partners within the condensate. We attribute LLPS to HNRNPK's RGG and Xist's repeat B (RepB) motifs. Mutating these motifs causes Xist diffusion, disrupts polycomb recruitment, and precludes the required mixing of chromosomal compartments for Xist's migration. Thus, we hypothesize that phase transitions in HNRNPK condensates allow Xist to locally concentrate silencing factors and to spread through internal channels of the HNRNPK-encapsulated chromosome.

Keywords: HNRNPK; RGG domain; RepB; Xist RNA; cis-limited spreading; condensates; deformability; droplets; liquid-liquid phase separation; repeat B.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests J.T.L. is a cofounder of Fulcrum Therapeutics, an advisor to Skyhawk Therapeutics, and a non-executive director of GSK. P.L. is a cofounder of NuPhase Therapeutics.

References

    1. Clemson C, McNeil J, Willard H, and Lawrence J. (1996). XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear/chromosome structure. The Journal of cell biology 132, 259–275. 10.1083/jcb.132.3.259. - DOI - PMC - PubMed
    1. Engreitz J, Pandya-Jones A, McDonel P, Shishkin A, Sirokman K, Surka C, Kadri S, Xing J, Goren A, Lander E, et al. (2013). The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science (New York, N.Y.) 341, 1237973. 10.1126/science.1237973. - DOI - PMC - PubMed
    1. Simon MD, Pinter SF, Fang R, Sarma K, Rutenberg-Schoenberg M, Bowman SK, Kesner BA, Maier VK, Kingston RE, and Lee JT (2013). High-resolution Xist binding maps reveal two-step spreading during X-chromosome inactivation. Nature 504, 465–469. 10.1038/nature12719. - DOI - PMC - PubMed
    1. Jeon Y, and Lee J. (2011). YY1 tethers Xist RNA to the inactive X nucleation center. Cell 146, 119–152. 10.1016/j.cell.2011.06.026. - DOI - PMC - PubMed
    1. Minajigi A, Froberg J, Wei C, Sunwoo H, Kesner B, Colognori D, Lessing D, Payer B, Boukhali M, Haas W, and Lee JT (2015). Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation. Science 349. 10.1126/science.aab2276aab2276. - DOI - PMC - PubMed

Substances

LinkOut - more resources